China / Yangtze River Pharmaceutical Group (YRPG) in Profile
One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River…
In March 2018, German pharma player Boehringer Ingelheim (BI)'s Consanas Rehabilitation and the Shanghai International Medical Center (SIMC) jointly established a Rehabilitation Medicine Center for stroke patients with the mission…
One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River…
HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T:…
The latest from Chinese pharma, including a new deal between AstraZeneca and Junshi Biosciences; Innoforce and…
Dr Yi (York) Chen, VP for operations and commercial planning at Arctic Vision shares his priorities, his wide experience of ophthalmology product launches in China, and how the company is positioning itself in relation to much larger companies in the Chinese ophthalmology market. Fundamentally, we are convinced that the China ophthalmology market is still a relatively blank slate with…
The Top 10 Chinese pharma companies for 2020 ranked by overall revenues. Taken from Fortune magazine’s 2020…
On March 30, 2020, the State Administration for Market Regulation (SAMR) enacted the Amended Drug Registration…
Click here to register and download PharmaBoardroom’s latest report: Healthcare & Life Sciences Review:…
One of the more eye-catching and ambitious initiatives to come out of last March’s National People’s Congress,…
China is set to become the second largest market for Mundipharma’s OxyContin behind the US. It comes as…
Kevin Rufang Huang is the president and founder of the Chinese Organization for Rare Disorders (CORD). A rare…
Given the undeniably challenging and dynamic China market, most industry stakeholders would agree that the…
Founded in 2009 by CEO Dr XU Ting, Alphamab started its journey as a protein engineering company with the ultimate…
A roundup of the latest news in Chinese pharma, including a US IPO for Burning Rock Biotech, positive news on…
A roundup of some of the top stories in China’s healthcare and life sciences industry, including challenges for…
Chinese biotech CanSinoBIO is racing against the clock to have a COVID-19 vaccine ready to begin production in…
On 26 August 2019, the Chinese legislature, the National People’s Congress (NPC), passed the new Drug…
Top recent news from Chinese pharma, including listings on the Hong Kong Stock Exchange, Junshi’s…
A selection of recent big stories from Chinese pharma, including Novo Nordisk’s updated China strategy,…
Lydia Guo, Grace Zhao and Mendy Zhang of executive search firm Egon Zehnder outline some of the latest trends…
Recent news from the cross-border deals and partnerships being struck by Chinese pharmacos, including I-Mab’s USD…
One of China’s biggest vaccine manufacturers was found to have falsified rabies vaccine records causing…
The lowdown on what it takes to be a country manager of a multinational pharma company in some of the world’s…
One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River…
Eurasia Group’s Aditya Bhattacharji examines the unfolding coronavirus outbreak, the prospects for…
PharmaBoardroom had the pleasure of interviewing HitGen chairman & CEO Dr Jin LI in July regarding the…
China’s regulator approved a biosimilar version of Roche’s Rituxan this week, the first such drug ever to be…
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact…
Earlier this year, PharmaBoardroom highlighted five of the most innovative and important biotech companies making…
Cash has always ruled the start-up world and when it comes to the healthcare and life sciences sphere, the heavy…
The Greater Bay Area’s – and in particular, Shenzhen’s – prowess in life sciences manufacturing…
In March 2018, German pharma player Boehringer Ingelheim (BI)‘s Consanas Rehabilitation and the Shanghai…
PharmaBoardroom recently analysed the contents of 10 interviews conducted with country managers at multinational…
The collaboration between BioNTech and Pfizer on a COVID-19 vaccine candidate based on mRNA technology continues…
As patients and consumers grow more educated and proactive in managing their own health and wellbeing, new ventures…